SNOA Stock Earnings: Sonoma Pharmaceuticals Misses EPS, Misses Revenue for Q1 2025

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

SNOA stock results show that Sonoma Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2025.

The post SNOA Stock Earnings: Sonoma Pharmaceuticals Misses EPS, Misses Revenue for Q1 2025 appeared first on InvestorPlace.

• Legendary Investor Predicts: “Forget AI... THIS Technology Is the Future”